-
1
-
-
57349198641
-
Granulysin is a key mediator for disseminated keratinocyte death in Stevens- Johnson syndrome and toxic epidermal necrolysis
-
Chung WH, Hung SI, Yang JY et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens- Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008;14:1343-50
-
(2008)
Nat Med
, vol.14
, pp. 1343-1350
-
-
Chung, W.H.1
Hung, S.I.2
Yang, J.Y.3
-
2
-
-
0028243480
-
The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification
-
Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994;102:28S-30.
-
(1994)
J Invest Dermatol
, vol.102
-
-
Roujeau, J.C.1
-
3
-
-
0028077408
-
Severe adverse cutaneous reactions to drugs
-
Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85
-
(1994)
N Engl J Med
, vol.331
, pp. 1272-1285
-
-
Roujeau, J.C.1
Stern, R.S.2
-
4
-
-
0025166471
-
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis
-
Chan HL, Stern RS, Arndt KA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43-7
-
(1990)
A Population-based Study With Particular Reference to Reactions Caused By Drugs Among Outpatients. Arch Dermatol
, vol.126
, pp. 43-47
-
-
Chan, H.L.1
Stern, R.S.2
Arndt, K.A.3
-
5
-
-
20944452153
-
Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome
-
Di Pascuale MA, Espana EM, Liu DT et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 2005;112: 904-12
-
(2005)
Ophthalmology
, vol.112
, pp. 904-912
-
-
Di Pascuale, M.A.1
Espana, E.M.2
Liu, D.T.3
-
7
-
-
15144352793
-
Pulmonary complications in toxic epidermal necrolysis: A prospective clinical study
-
Lebargy F, Wolkenstein P, Gisselbrecht M et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 1997;23:1237-44.
-
(1997)
Intensive Care Med
, vol.23
, pp. 1237-1244
-
-
Lebargy, F.1
Wolkenstein, P.2
Gisselbrecht, M.3
-
8
-
-
0031671629
-
Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: A patient who excreted long tubes of dead intestinal epithelium
-
Sugimoto Y, Mizutani H, Sato T, Kawamura N, Ohkouchi K, Shimizu M. Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium. J Dermatol 1998;25:533-8
-
(1998)
J Dermatol
, vol.25
, pp. 533-538
-
-
Sugimoto, Y.1
Mizutani, H.2
Sato, T.3
Kawamura, N.4
Ohkouchi, K.5
Shimizu, M.6
-
9
-
-
0036722828
-
Outcome of patients with toxic epidermal necrolysis syndrome revisited
-
Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM. Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg 2002;110:768-73
-
(2002)
Plast Reconstr Surg
, vol.110
, pp. 768-773
-
-
Ducic, I.1
Shalom, A.2
Rising, W.3
Nagamoto, K.4
Munster, A.M.5
-
10
-
-
0029873975
-
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
-
Paul C, Wolkenstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-4
-
(1996)
Br J Dermatol
, vol.134
, pp. 710-714
-
-
Paul, C.1
Wolkenstein, P.2
Adle, H.3
-
11
-
-
0032538505
-
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
-
Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3
-
(1998)
Science
, vol.282
, pp. 490-493
-
-
Viard, I.1
Wehrli, P.2
Bullani, R.3
-
12
-
-
1842784823
-
Medical genetics: A marker for Stevens-Johnson syndrome
-
Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428: 486.
-
(2004)
Nature
, vol.428
, pp. 486
-
-
Chung, W.H.1
Hung, S.I.2
Hong, H.S.3
-
13
-
-
33646934721
-
A marker for Stevens- Johnson syndrome...: Ethnicity matters
-
Lonjou C, Thomas L, Borot N et al. A marker for Stevens- Johnson syndrome...: ethnicity matters. Pharmacogenomics J 2006;6:265-8
-
(2006)
Pharmacogenomics J
, vol.6
, pp. 265-268
-
-
Lonjou, C.1
Thomas, L.2
Borot, N.3
-
14
-
-
61549115662
-
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
-
Kaniwa N, Saito Y, Aihara M et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008;9:1617-22
-
(2008)
Pharmacogenomics
, vol.9
, pp. 1617-1622
-
-
Kaniwa, N.1
Saito, Y.2
Aihara, M.3
-
15
-
-
85031244783
-
-
Allele Frequencies in Worldwide Populations. Available from
-
Allele Frequencies in Worldwide Populations. Available from http://www.allelefrequencies.net/.
-
-
-
-
16
-
-
57449118501
-
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
-
Locharernkul C, Loplumlert J, Limotai C et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008;49:2087-91
-
(2008)
Epilepsia
, vol.49
, pp. 2087-2091
-
-
Locharernkul, C.1
Loplumlert, J.2
Limotai, C.3
-
17
-
-
69749090332
-
Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson Syndrome in Malaysian population
-
Chang CC, Too CL, Murad S. Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson Syndrome in Malaysian population. Proceeding in 7th Asian-Oceanian Epilepsy Congress, Xiamen. 2008.
-
(2008)
Proceeding In 7th Asian-Oceanian Epilepsy Congress, Xiamen
-
-
Chang, C.C.1
Too, C.L.2
Murad, S.3
-
18
-
-
69749108001
-
HLA-A, -B, -Cw, -DQA1, -DQB1 and -DRB1 alleles and KIR alleles in a Hindu population from Punjab
-
Rajalingam R, Parham P, Mehra NK. HLA-A, -B, -Cw, -DQA1, -DQB1 and -DRB1 alleles and KIR alleles in a Hindu population from Punjab, India. Human Immunology 2004;65:958-60
-
(2004)
India. Human Immunology
, vol.65
, pp. 958-960
-
-
Rajalingam, R.1
Parham, P.2
Mehra, N.K.3
-
19
-
-
70450205028
-
Association of HLA-B*1502 allele and carbamazepine-induced Stevens- Johnson syndrome among Indians
-
Mehta TY, Prajapati LM, Mittal B et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens- Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009;75:579-82
-
(2009)
Indian J Dermatol Venereol Leprol
, vol.75
, pp. 579-582
-
-
Mehta, T.Y.1
Prajapati, L.M.2
Mittal, B.3
-
20
-
-
75649107833
-
HLA class I markers in Japanese patients with carbamazepineinduced cutaneous adverse reactions
-
Ikeda H, Takahashi Y, Yamazaki E et al. HLA class I markers in Japanese patients with carbamazepineinduced cutaneous adverse reactions. Epilepsia 2010;51: 297-300
-
(2010)
Epilepsia
, vol.51
, pp. 297-300
-
-
Ikeda, H.1
Takahashi, Y.2
Yamazaki, E.3
-
21
-
-
41549083321
-
HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
-
Ueta M, Tokunaga K, Sotozono C et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis 2008;14:550-5
-
(2008)
Mol Vis
, vol.14
, pp. 550-555
-
-
Ueta, M.1
Tokunaga, K.2
Sotozono, C.3
-
22
-
-
15244349566
-
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
-
U S A
-
Hung SI, Chung WH, Liou LB et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005; 102:4134-9
-
(2005)
Proc Natl Acad Sci
, vol.102
, pp. 4134-4139
-
-
Hung, S.I.1
Chung, W.H.2
Liou, L.B.3
-
23
-
-
70249122727
-
Strong association between HLA-B*5801 and allopurinolinduced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
-
Tassaneeyakul W, Jantararoungtong T, Chen P et al. Strong association between HLA-B*5801 and allopurinolinduced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 2009;19:704-9
-
(2009)
Pharmacogenet Genomics
, vol.19
, pp. 704-709
-
-
Tassaneeyakul, W.1
Jantararoungtong, T.2
Chen, P.3
-
24
-
-
56749148531
-
HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions
-
Kano Y, Hirahara K, Asano Y, Shiohara T. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008;88:616-8
-
(2008)
Acta Derm Venereol
, vol.88
, pp. 616-618
-
-
Kano, Y.1
Hirahara, K.2
Asano, Y.3
Shiohara, T.4
-
25
-
-
38149108354
-
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
-
Lonjou C, Borot N, Sekula P et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008;18:99-107
-
(2008)
Pharmacogenet Genomics
, vol.18
, pp. 99-107
-
-
Lonjou, C.1
Borot, N.2
Sekula, P.3
-
26
-
-
0037006623
-
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
-
Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002;359:727-32
-
(2002)
Lancet
, vol.359
, pp. 727-732
-
-
Mallal, S.1
Nolan, D.2
Witt, C.3
-
27
-
-
38949196447
-
HLA-B*5701 screening for hypersensitivity to abacavir
-
Mallal S, Phillips E, Carosi G et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008;358: 568-79
-
(2008)
N Engl J Med
, vol.358
, pp. 568-579
-
-
Mallal, S.1
Phillips, E.2
Carosi, G.3
-
28
-
-
58749103488
-
Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?
-
Park WB, Choe PG, Song KH et al. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir? Clin Infect Dis 2009;48:365-7
-
(2009)
Clin Infect Dis
, vol.48
, pp. 365-367
-
-
Park, W.B.1
Choe, P.G.2
Song, K.H.3
-
29
-
-
7944234979
-
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
-
Nassif A, Bensussan A, Boumsell L et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004;114:1209-15
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 1209-1215
-
-
Nassif, A.1
Bensussan, A.2
Boumsell, L.3
-
30
-
-
0030822702
-
Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones
-
Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997;100:136-41
-
(1997)
J Clin Invest
, vol.100
, pp. 136-141
-
-
Schnyder, B.1
Mauri-Hellweg, D.2
Zanni, M.3
Bettens, F.4
Pichler, W.J.5
-
31
-
-
0030020194
-
Cell immune responses to haptens
-
Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1996;107:141-51
-
(1996)
Structural models for allergic and autoimmune reactions Toxicology
, vol.107
, pp. 141-151
-
-
Weltzien, H.U.1
Moulon, C.2
Martin, S.3
Padovan, E.4
Hartmann, U.5
Kohler, J.T.6
-
32
-
-
0036676978
-
Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept
-
Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002;2:301-5
-
(2002)
Curr Opin Allergy Clin Immunol
, vol.2
, pp. 301-305
-
-
Pichler, W.J.1
-
33
-
-
0344951264
-
Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
-
Naisbitt DJ, Britschgi M, Wong G et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003;63:732-41
-
(2003)
Mol Pharmacol
, vol.63
, pp. 732-741
-
-
Naisbitt, D.J.1
Britschgi, M.2
Wong, G.3
-
34
-
-
34948839971
-
HLA-B*1502-bound peptides: Implications for the pathogenesis of carbamazepineinduced Stevens-Johnson syndrome
-
Yang CW, Hung SI, Juo CG et al. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepineinduced Stevens-Johnson syndrome. J Allergy Clin Immunol 2007;120:870-7
-
(2007)
J Allergy Clin Immunol
, vol.120
, pp. 870-877
-
-
Yang, C.W.1
Hung, S.I.2
Juo, C.G.3
-
35
-
-
0031568384
-
Polymorphism in the alpha 1 helix of the HLAB heavy chain can have an overriding influence on peptide-binding specificity
-
Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P. Polymorphism in the alpha 1 helix of the HLAB heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 1997;158:1660-9
-
(1997)
J Immunol
, vol.158
, pp. 1660-1669
-
-
Barber, L.D.1
Percival, L.2
Arnett, K.L.3
Gumperz, J.E.4
Chen, L.5
Parham, P.6
-
36
-
-
0023234595
-
Human T cell clones use a CD3- associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity
-
David V, Bourge JF, Guglielmi P, Mathieu-Mahul D, Degos L, Bensussan A. Human T cell clones use a CD3- associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. J Immunol 1987;138:2831-6
-
(1987)
J Immunol
, vol.138
, pp. 2831-2836
-
-
David, V.1
Bourge, J.F.2
Guglielmi, P.3
Mathieu-Mahul, D.4
Degos, L.5
Bensussan, A.6
-
37
-
-
0033956005
-
Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors
-
Le Cleach L, Delaire S, Boumsell L et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000;119: 225-30
-
(2000)
Clin Exp Immunol
, vol.119
, pp. 225-230
-
-
Le Cleach, L.1
Delaire, S.2
Boumsell, L.3
-
39
-
-
6344225554
-
Evaluation of the potential role of cytokines in toxic epidermal necrolysis
-
Nassif A, Moslehi H, Le Gouvello S et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 2004;123:850-5
-
(2004)
J Invest Dermatol
, vol.123
, pp. 850-855
-
-
Nassif, A.1
Moslehi, H.2
Le Gouvello, S.3
-
40
-
-
0037507304
-
Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions
-
Viard-Leveugle I, Bullani RR, Meda P et al. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem 2003;278:16183-8
-
(2003)
J Biol Chem
, vol.278
, pp. 16183-16188
-
-
Viard-Leveugle, I.1
Bullani, R.R.2
Meda, P.3
-
42
-
-
0037438360
-
Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand
-
Knox PG, Milner AE, Green NK, Eliopoulos AG, Young LS. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J Immunol 2003;170:677-85
-
(2003)
J Immunol
, vol.170
, pp. 677-685
-
-
Knox, P.G.1
Milner, A.E.2
Green, N.K.3
Eliopoulos, A.G.4
Young, L.S.5
-
43
-
-
1442351940
-
Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis
-
Chang HY, Cooper ZA, Swetter SM, Marinkovich MP. Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis. Arch Dermatol 2004;140:242-4
-
(2004)
Arch Dermatol
, vol.140
, pp. 242-244
-
-
Chang, H.Y.1
Cooper, Z.A.2
Swetter, S.M.3
Marinkovich, M.P.4
-
44
-
-
0036469109
-
Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas
-
Filipowicz E, Adegboyega P, Sanchez RL, Gatalica Z. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer 2002;94:814-9
-
(2002)
Cancer
, vol.94
, pp. 814-819
-
-
Filipowicz, E.1
Adegboyega, P.2
Sanchez, R.L.3
Gatalica, Z.4
-
45
-
-
0037407710
-
Toxic epidermal necrolysis and Stevens- Johnson syndrome are induced by soluble Fas ligand
-
Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens- Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162:1515-20
-
(2003)
Am J Pathol
, vol.162
, pp. 1515-1520
-
-
Abe, R.1
Shimizu, T.2
Shibaki, A.3
Nakamura, H.4
Watanabe, H.5
Shimizu, H.6
-
46
-
-
0026619247
-
The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens- Johnson syndrome
-
in Italian)
-
Amato GM, Travia A, Ziino O. [The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens- Johnson syndrome]. Pediatr Med Chir 1992;14:555-6 (in Italian).
-
(1992)
Pediatr Med Chir
, pp. 555-556
-
-
Amato, G.M.1
Travia, A.2
Ziino, O.3
-
47
-
-
0033883496
-
Death receptors in cutaneous biology and disease
-
Wehrli P, Viard I, Bullani R, Tschopp J, French LE. Death receptors in cutaneous biology and disease. J Invest Dermatol 2000;115:141-8
-
(2000)
J Invest Dermatol
, vol.115
, pp. 141-148
-
-
Wehrli, P.1
Viard, I.2
Bullani, R.3
Tschopp, J.4
French, L.E.5
-
48
-
-
0037233824
-
Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression
-
Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-6
-
(2003)
Arch Dermatol
, vol.139
, pp. 33-36
-
-
Bachot, N.1
Revuz, J.2
Roujeau, J.C.3
-
49
-
-
37349096285
-
Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study
-
Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008;58: 33-40
-
(2008)
J Am Acad Dermatol
, vol.58
, pp. 33-40
-
-
Schneck, J.1
Fagot, J.P.2
Sekula, P.3
Sassolas, B.4
Roujeau, J.C.5
Mockenhaupt, M.6
-
50
-
-
77957055812
-
Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis
-
May
-
Valeyrie-Allanore L, Wolkenstein P, Brochard L et al. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. Epub 2010 May 25.
-
(2010)
Br J Dermatol. Epub
, pp. 25
-
-
Valeyrie-Allanore, L.1
Wolkenstein, P.2
Brochard, L.3
-
51
-
-
77953592420
-
Severe cutaneous adverse drug reactions: Who should treat, where and how?: Facts and controversies
-
Wolf R, Davidovici B. Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies. Clin Dermatol 2010;28:344-8
-
(2010)
Clin Dermatol
, vol.28
, pp. 344-348
-
-
Wolf, R.1
Davidovici, B.2
-
52
-
-
34047267273
-
Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome
-
Mittmann N, Chan B, Knowles S, Cosentino L, Shear N. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 2006;7:359-68
-
(2006)
Am J Clin Dermatol
, vol.7
, pp. 359-368
-
-
Mittmann, N.1
Chan, B.2
Knowles, S.3
Cosentino, L.4
Shear, N.5
-
53
-
-
0036152644
-
Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity
-
Posadas SJ, Padial A, Torres MJ et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002;109:155-61
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 155-161
-
-
Posadas, S.J.1
Padial, A.2
Torres, M.J.3
-
54
-
-
0036230022
-
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
-
Nassif A, Bensussan A, Dorothee G et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002;118:728-33
-
(2002)
J Invest Dermatol
, vol.118
, pp. 728-733
-
-
Nassif, A.1
Bensussan, A.2
Dorothee, G.3
-
55
-
-
0025230476
-
Perforin-mediated target cell lysis by cytolytic T lymphocytes
-
Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990;8: 279-302
-
(1990)
Annu Rev Immunol
, vol.8
, pp. 279-302
-
-
Tschopp, J.1
Nabholz, M.2
-
56
-
-
0028947976
-
Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
-
Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995;198:1-24
-
(1995)
Curr Top Microbiol Immunol
, vol.198
, pp. 1-24
-
-
Lowin, B.1
Peitsch, M.C.2
Tschopp, J.3
-
57
-
-
0029099845
-
Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
-
Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-8
-
(1995)
Nature
, vol.377
, pp. 446-448
-
-
Darmon, A.J.1
Nicholson, D.W.2
Bleackley, R.C.3
-
58
-
-
0028279347
-
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis
-
Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-8.
-
(1994)
Arch Dermatol
, vol.130
, pp. 605-608
-
-
Paquet, P.1
Nikkels, A.2
Arrese, J.E.3
Vanderkelen, A.4
Pierard, G.E.5
-
59
-
-
0343036291
-
Erythema multiforme and toxic epidermal necrolysis: A comparative study
-
Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 1997;19:127-32
-
(1997)
Am J Dermatopathol
, vol.19
, pp. 127-132
-
-
Paquet, P.1
Pierard, G.E.2
-
60
-
-
0033564708
-
Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines
-
Arnold R, Seifert M, Asadullah K, Volk HD. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 1999;162:7140-7
-
(1999)
J Immunol
, vol.162
, pp. 7140-7147
-
-
Arnold, R.1
Seifert, M.2
Asadullah, K.3
Volk, H.D.4
-
61
-
-
0033084012
-
TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation
-
Zhuang L, Wang B, Shinder GA, Shivji GM, Mak TW, Sauder DN. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999;162:1440-7
-
(1999)
J Immunol
, vol.162
, pp. 1440-1447
-
-
Zhuang, L.1
Wang, B.2
Shinder, G.A.3
Shivji, G.M.4
Mak, T.W.5
Sauder, D.N.6
-
62
-
-
0033739225
-
High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo
-
Ruckert R, Lindner G, Bulfone-Paus S, Paus R. High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 2000;143:1036-9
-
(2000)
Br J Dermatol
, vol.143
, pp. 1036-1039
-
-
Ruckert, R.1
Lindner, G.2
Bulfone-Paus, S.3
Paus, R.4
-
63
-
-
0033975513
-
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
-
Leverkus M, Neumann M, Mengling T et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 2000;60:553-9
-
(2000)
Cancer Res
, vol.60
, pp. 553-559
-
-
Leverkus, M.1
Neumann, M.2
Mengling, T.3
-
64
-
-
0032905030
-
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
-
Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999;5:412-7
-
(1999)
Nat Med
, vol.5
, pp. 412-417
-
-
Wang, C.Y.1
Cusack Jr., J.C.2
Liu, R.3
Baldwin Jr., A.S.4
-
65
-
-
0033621279
-
Role of NF-kappaB in the apoptoticresistant phenotype of keratinocytes
-
Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-kappaB in the apoptoticresistant phenotype of keratinocytes. J Biol Chem 1999; 274:37957-64
-
(1999)
J Biol Chem
, vol.274
, pp. 37957-37964
-
-
Qin, J.Z.1
Chaturvedi, V.2
Denning, M.F.3
Choubey, D.4
Diaz, M.O.5
Nickoloff, B.J.6
-
66
-
-
0032517486
-
Randomised comparison of thalidomide versus placebo in toxic epider 332
-
Lancet
-
Wolkenstein P, Latarjet J, Roujeau JC et al. Randomised comparison of thalidomide versus placebo in toxic epider 332 Allergology International Vol 59, No 4, 2010 www.jsaweb.jp/malnecrolysis. Lancet 1998;352:1586-9
-
(2010)
Allergology International
, vol.59
, Issue.4
, pp. 1586-1589
-
-
Wolkenstein, P.1
Latarjet, J.2
Roujeau, J.C.3
-
67
-
-
0032529629
-
Granulysin-induced apoptosis
-
I. Involvement of at least two distinct pathways
-
Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998;161:1758-64
-
(1998)
J Immunol
, vol.161
, pp. 1758-1764
-
-
Gamen, S.1
Hanson, D.A.2
Kaspar, A.3
Naval, J.4
Krensky, A.M.5
Anel, A.6
-
68
-
-
0032475823
-
An antimicrobial activity of cytolytic T cells mediated by granulysin
-
Stenger S, Hanson DA, Teitelbaum R et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998;282:121-5
-
(1998)
Science
, vol.282
, pp. 121-125
-
-
Stenger, S.1
Hanson, D.A.2
Teitelbaum, R.3
-
69
-
-
0032793656
-
Biosynthesis of granulysin, a novel cytolytic molecule
-
Hanson DA, Kaspar AA, Poulain FR, Krensky AM. Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol 1999;36:413-22
-
(1999)
Mol Immunol
, vol.36
, pp. 413-422
-
-
Hanson, D.A.1
Kaspar, A.A.2
Poulain, F.R.3
Krensky, A.M.4
-
70
-
-
17844405622
-
Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator
-
Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005; 174:5243-8.
-
(2005)
J Immunol
, vol.174
, pp. 5243-5248
-
-
Deng, A.1
Chen, S.2
Li, Q.3
Lyu, S.C.4
Clayberger, C.5
Krensky, A.M.6
|